PanGen Biotech Inc (222110) — Capital Reinvestment Ratio

Latest as of June 2025: 0.02x

PanGen Biotech Inc (222110) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩3.22 Billion) in capital expenditures (₩56.30 Million). See PanGen Biotech Inc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

₩3.22 Billion

KRW

Capital Expenditures

₩56.30 Million

KRW

Data as of

Jun 2025

Most recent filing

PanGen Biotech Inc Capital Reinvestment Ratio (2024–2024)

This chart tracks PanGen Biotech Inc's Capital Reinvestment Ratio across 1 annual periods. Check PanGen Biotech Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for PanGen Biotech Inc (2024–2024)

Year-by-year Capital Reinvestment Ratio for PanGen Biotech Inc from 2024 to 2024. For live market cap and broader valuation context, see PanGen Biotech Inc market cap and net worth.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2024	0.13x	₩2.99 Billion	₩374.12 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow